HLHongyi Liu

Hongyi Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongyi Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Cheng

    Department of Neurosurgery, Wuxi People's Hospital of Nanjing Medical University, Wuxi, PR China

    2 shared publications
  • Junfei Shao

    Department of Neurosurgery, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, China

    2 shared publications
  • Wei Ji

    Department of Neurosurgery, Wuxi People's Hospital of Nanjing Medical University, Wuxi, PR China; Department of Neurosurgery, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, PR China

    2 shared publications
  • Bin Xu

    Department of Neurosurgery, Wuxi People’s Hospital of Nanjing Medical University

    1 shared publication
  • Jiantong Jiao

    Department of Neurosurgery, Wuxi People's Hospital of Nanjing Medical University, Wuxi, PR China

    1 shared publication
  • Jiantong Jiao

    Department of Neurosurgery, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, China

    1 shared publication

Latest Publications

  • A positive feedback loop of LINC00662 and STAT3 promotes malignant phenotype of glioma

    by Wei Ji, Jiantong Jiao, Chao Cheng, Yong Xiao, Junfei Shao, Hongyi Liu


  • Open Access

    Bioinformatics Analysis of Expression Profiles and Prognostic Values of the Signal Transducer and Activator of Transcription Family Genes in Glioma

    by Wei Ji, Yuankun Liu, Bin Xu, Jie Mei, Chao Cheng, Yong Xiao, Kun Yang, Weiyi Huang, Jiantong Jiao, Hongyi Liu, et al.

    Signal transducer and activator of transcription (STAT) family genes—of which there are seven members: STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, and STAT6—have been associated with the progression of multiple cancers. However, their prognostic values in glioma remain unclear. In this study, we systematically investigated the expression, the prognostic value, and the potential mechanism of the STAT family genes in glioma. The expression of STAT1/2/3/5A/6 members were significantly higher and positively correlated with IDH mutations, while the expression of STAT5B was lower and negatively correlated with IDH mutations in glioma. Survival analysis indicated that the upregulation of STAT1/2/3/5A/6 and downregulation of STAT5B expression was associated with poorer overall survival in glioma. Joint effects analysis of STAT1/2/3/5A/5B/6 expression suggested that the prognostic value of the group was more significant than that of each individual gene. Thus, we constructed a risk score model to predict the prognosis of glioma. The receiver operating characteristic curve and calibration curves showed good performance as prognostic indicators in both TCGA (The Cancer Genome Atlas) and the CGGA (Chinese Glioma Genome Atlas) databases. Furthermore, we analyzed the correlation between STAT expression with immune infiltration in glioma. The Protein–protein interaction network and enrichment analysis showed that STAT members and co-expressed genes mainly participated in signal transduction activity, Hepatitis B, the Jak-STAT signaling pathway, transcription factor activity, sequence-specific DNA binding, and the cytokine-mediated signaling pathway in glioma. In summary, our study analyzed the expression, prognostic values, and biological roles of the STAT gene family members in glioma, based on which we developed a new risk score model to predict the prognosis of glioma more precisely.